S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
All the trading advice you’ve ever received boils down to this (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
All the trading advice you’ve ever received boils down to this (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
All the trading advice you’ve ever received boils down to this (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
All the trading advice you’ve ever received boils down to this (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio

Fresenius Medical Care AG & Co. KGaA Stock Price, News & Analysis (ETR:FME)

€38.68
+0.68 (+1.79%)
(As of 12/4/2023 ET)
Compare
Today's Range
€37.98
€38.68
50-Day Range
€31.19
€42.00
52-Week Range
€28.82
€49.62
Volume
355,107 shs
Average Volume
704,197 shs
Market Capitalization
$11.35 billion
P/E Ratio
25.12
Dividend Yield
2.90%
Price Target
€29.77

Fresenius Medical Care AG & Co. KGaA MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
23.0% Downside
€29.77 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
1.52mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars


FME stock logo

About Fresenius Medical Care AG & Co. KGaA Stock (ETR:FME)

Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FME Stock Price History

FME Stock News Headlines

Fresenius Medical Care Completes Change Of Legal Form - Quick Facts
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Fresenius sells fertility business to KKR and GED Capital
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
12 Best German Stocks To Buy Now
Top Medical Stocks to Buy Amid Recent Market Volatility
Why Shares of Fresenius Medical Jumped This Week
See More Headlines
Receive FME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
123,106
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
€29.77
High Stock Price Target
€46.83
Low Stock Price Target
€17.10
Potential Upside/Downside
-21.7%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$449.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19.46 billion
Cash Flow
€3.85 per share
Book Value
€47.74 per share

Miscellaneous

Free Float
N/A
Market Cap
$11.15 billion
Optionable
Not Optionable
Beta
0.97
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Ms. Helen Giza (Age 55)
    CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
    Comp: $3.21M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 66)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $2.42M
  • Mr. William J. Valle (Age 63)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $3.93M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 60)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $2.35M
  • Mr. Roberto Fuste (Age 71)
    Executive Advisor for Regional Strategy
  • Mr. Martin Fischer (Age 46)
    CFO & Member of the Management Board of Fresenius Medical Care Management AG
  • Dr. Dominik Heger
    Executive VP and Head of Investor Relations, Strategic Development & Communications
  • Mr. Borries Von Muller (Age 62)
    Senior Vice President of Global Human Resources Employee Communications
  • Mr. Joachim Weith
    Senior Vice President of Corporate Communications & Governmental Affairs
  • Mr. Oliver Maier
    Senior Vice President Investor Relations














FME Stock Analysis - Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock price target for 2024?

0 brokerages have issued 12 month target prices for Fresenius Medical Care AG & Co. KGaA's stock. Their FME share price targets range from €17.10 to €46.83. On average, they expect the company's stock price to reach €29.77 in the next twelve months. This suggests that the stock has a possible downside of 23.0%.
View analysts price targets for FME
or view top-rated stocks among Wall Street analysts.

How have FME shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €30.57 at the beginning of the year. Since then, FME shares have increased by 26.5% and is now trading at €38.68.
View the best growth stocks for 2023 here
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) pays an annual dividend of €1.12 per share and currently has a dividend yield of 3.06%. The dividend payout ratio is 72.73%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Fresenius Medical Care AG & Co. KGaA (FMS), RWE Aktiengesellschaft (RWE), Deutsche Lufthansa (LHA), Rio Tinto Group (RIO), Covestro (1COV), Carillion (CLLN), Nokia Oyj (NOK) and Oxford Biomedica (OXB).

This page (ETR:FME) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -